BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 31014004)

  • 1. Return to Work Interventions for Cancer Survivors: A Systematic Review and a Methodological Critique.
    Lamore K; Dubois T; Rothe U; Leonardi M; Girard I; Manuwald U; Nazarov S; Silvaggi F; Guastafierro E; Scaratti C; Breton T; Foucaud J
    Int J Environ Res Public Health; 2019 Apr; 16(8):. PubMed ID: 31014004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of a tailored return to work program for cancer survivors with job loss: results of a randomized controlled trial.
    van Egmond MP; Duijts SF; Jonker MA; van der Beek AJ; Anema JR
    Acta Oncol; 2016; 55(9-10):1210-1219. PubMed ID: 27549145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes across the return-to-work process in PC survivors attending a rehabilitation measure-results from a prospective study.
    Ullrich A; Rath HM; Otto U; Kerschgens C; Raida M; Hagen-Aukamp C; Bergelt C
    Support Care Cancer; 2017 Oct; 25(10):3007-3015. PubMed ID: 28698950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Return to work of cancer patients after a multidisciplinary intervention including occupational counselling and physical exercise in cancer patients: a prospective study in the Netherlands.
    Leensen MCJ; Groeneveld IF; van der Heide I; Rejda T; van Veldhoven PLJ; Berkel SV; Snoek A; Harten WV; Frings-Dresen MHW; de Boer AGEM
    BMJ Open; 2017 Jun; 7(6):e014746. PubMed ID: 28619770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors for earlier return to work of cancer patients.
    Wolvers MDJ; Leensen MCJ; Groeneveld IF; Frings-Dresen MHW; De Boer AGEM
    J Cancer Surviv; 2018 Apr; 12(2):169-177. PubMed ID: 29076003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sociodemographic and disease-related determinants of return to work among women with breast cancer: a German longitudinal cohort study.
    Heuser C; Halbach S; Kowalski C; Enders A; Pfaff H; Ernstmann N
    BMC Health Serv Res; 2018 Dec; 18(1):1000. PubMed ID: 30594181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Return to work after breast cancer: The role of treatment-related side effects and potential impact on quality of life.
    Schmidt ME; Scherer S; Wiskemann J; Steindorf K
    Eur J Cancer Care (Engl); 2019 Jul; 28(4):e13051. PubMed ID: 31033073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Return to work in European Cancer survivors: a systematic review.
    Paltrinieri S; Fugazzaro S; Bertozzi L; Bassi MC; Pellegrini M; Vicentini M; Mazzini E; Costi S
    Support Care Cancer; 2018 Sep; 26(9):2983-2994. PubMed ID: 29845421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceived employer-related barriers and facilitators for work participation of cancer survivors: A systematic review of employers' and survivors' perspectives.
    Greidanus MA; de Boer AGEM; de Rijk AE; Tiedtke CM; Dierckx de Casterlé B; Frings-Dresen MHW; Tamminga SJ
    Psychooncology; 2018 Mar; 27(3):725-733. PubMed ID: 28753741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a self-managed return to work intervention for colorectal cancer survivors: A prospective randomized controlled trial.
    Park SY; Lee MK
    Eur J Oncol Nurs; 2024 Jun; 70():102593. PubMed ID: 38795437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prevalence and Determinants of Return to Work in Nasopharyngeal Carcinoma Survivors.
    So N; McDowell LJ; Lu L; Xu W; Rock K; Waldron J; Bernstein LJ; Chan HB; Huang SH; Giuliani M; Hope A; O'Sullivan B; Bratman SV; Cho J; Kim J; Jang R; Bayley A; Ringash J
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):134-145. PubMed ID: 31568813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Return to work in survivors of Primary Brain Tumours treated with Intensity Modulated Radiotherapy.
    Basalathullah MAR; Malik M; Valiyaveettil D; Elizabeth NB; Ahmed SF
    Cancer Treat Res Commun; 2021; 26():100302. PubMed ID: 33440331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Returning to work after breast cancer: A systematic review of reviews.
    Cocchiara RA; Sciarra I; D'Egidio V; Sestili C; Mancino M; Backhaus I; Mannocci A; De Luca A; Frusone F; Di Bella O; Di Murro F; Palmeri V; Lia L; Paradiso G; Aceti V; Libia A; Monti M; La Torre G
    Work; 2018; 61(3):463-476. PubMed ID: 30400123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-Year Prospective Cohort Study of Factors Associated with Return to Work After Breast Cancer Diagnosis.
    Lee MK; Kang HS; Lee KS; Lee ES
    J Occup Rehabil; 2017 Dec; 27(4):547-558. PubMed ID: 27858198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Return to work after a cancer diagnosis: a meta-review of reviews and a meta-synthesis of recent qualitative studies.
    Butow P; Laidsaar-Powell R; Konings S; Lim CYS; Koczwara B
    J Cancer Surviv; 2020 Apr; 14(2):114-134. PubMed ID: 31858379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Return to work in prostate cancer survivors - findings from a prospective study on occupational reintegration following a cancer rehabilitation program.
    Ullrich A; Rath HM; Otto U; Kerschgens C; Raida M; Hagen-Aukamp C; Bergelt C
    BMC Cancer; 2018 Jul; 18(1):751. PubMed ID: 30029637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Return to work after breast cancer treatments: Rebuilding everything despite feeling "in-between".
    Bilodeau K; Tremblay D; Durand MJ
    Eur J Oncol Nurs; 2019 Aug; 41():165-172. PubMed ID: 31358250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A scoping review of return to work decision-making and experiences of breast cancer survivors in Korea.
    Sohn KJ; Park SY; Kim S
    Support Care Cancer; 2021 Apr; 29(4):1741-1751. PubMed ID: 33070232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a return-to-work planning tool for cancer survivors: Élaboration d'un outil de planification du retour au travail pour les survivants du cancer.
    Amin L; Stergiou-Kita M; Jones JM
    Can J Occup Ther; 2017; 84(4-5):223-228. PubMed ID: 28494611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Return to work experiences of patients treated with stem cell transplantation for a hematologic malignancy.
    Persoon S; Buffart LM; Chinapaw MJM; Nollet F; Frings-Dresen MH; Koning S; Kersten MJ; Tamminga SJ
    Support Care Cancer; 2019 Aug; 27(8):2987-2997. PubMed ID: 30591967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.